Global Hereditary Cancer Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Hereditary Cancer Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hereditary Cancer Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Hereditary Cancer Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While RNA Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hereditary Cancer Testing include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, and BioReference Laboratories (GeneDx), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hereditary Cancer Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Hereditary Cancer Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hereditary Cancer Testing, with revenue, gross margin and global market share of Hereditary Cancer Testing from 2019 to 2022.
Chapter 3, the Hereditary Cancer Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hereditary Cancer Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hereditary Cancer Testing research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hereditary Cancer Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Hereditary Cancer Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While RNA Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hereditary Cancer Testing include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, and BioReference Laboratories (GeneDx), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hereditary Cancer Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- RNA Testing
- DNA Testing
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other Cancers
- Ambry Genetics (Konica Minota)
- Asper Biogene
- Natera
- Caris Life Sciences
- BioReference Laboratories (GeneDx)
- LabSolutions
- Progenity?Inc
- ARUP Laboratories
- Myriad
- NeoGenomics
- Blueprint Genetics
- CellMax Life
- Fulgent Genetics
- Strand Life Sciences
- Myogenes
- LabCorp
- Quest Diagnostics
- Pathway Genomics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Hereditary Cancer Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hereditary Cancer Testing, with revenue, gross margin and global market share of Hereditary Cancer Testing from 2019 to 2022.
Chapter 3, the Hereditary Cancer Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hereditary Cancer Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hereditary Cancer Testing research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hereditary Cancer Testing
1.2 Classification of Hereditary Cancer Testing by Type
1.2.1 Overview: Global Hereditary Cancer Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Hereditary Cancer Testing Revenue Market Share by Type in 2021
1.2.3 RNA Testing
1.2.4 DNA Testing
1.3 Global Hereditary Cancer Testing Market by Application
1.3.1 Overview: Global Hereditary Cancer Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Global Hereditary Cancer Testing Market Size & Forecast
1.5 Global Hereditary Cancer Testing Market Size and Forecast by Region
1.5.1 Global Hereditary Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Hereditary Cancer Testing Market Size by Region, (2017-2022)
1.5.3 North America Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.6 South America Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hereditary Cancer Testing Market Drivers
1.6.2 Hereditary Cancer Testing Market Restraints
1.6.3 Hereditary Cancer Testing Trends Analysis
2 COMPANY PROFILES
2.1 Ambry Genetics (Konica Minota)
2.1.1 Ambry Genetics (Konica Minota) Details
2.1.2 Ambry Genetics (Konica Minota) Major Business
2.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product and Solutions
2.1.4 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Ambry Genetics (Konica Minota) Recent Developments and Future Plans
2.2 Asper Biogene
2.2.1 Asper Biogene Details
2.2.2 Asper Biogene Major Business
2.2.3 Asper Biogene Hereditary Cancer Testing Product and Solutions
2.2.4 Asper Biogene Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Asper Biogene Recent Developments and Future Plans
2.3 Natera
2.3.1 Natera Details
2.3.2 Natera Major Business
2.3.3 Natera Hereditary Cancer Testing Product and Solutions
2.3.4 Natera Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Natera Recent Developments and Future Plans
2.4 Caris Life Sciences
2.4.1 Caris Life Sciences Details
2.4.2 Caris Life Sciences Major Business
2.4.3 Caris Life Sciences Hereditary Cancer Testing Product and Solutions
2.4.4 Caris Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Caris Life Sciences Recent Developments and Future Plans
2.5 BioReference Laboratories (GeneDx)
2.5.1 BioReference Laboratories (GeneDx) Details
2.5.2 BioReference Laboratories (GeneDx) Major Business
2.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product and Solutions
2.5.4 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BioReference Laboratories (GeneDx) Recent Developments and Future Plans
2.6 LabSolutions
2.6.1 LabSolutions Details
2.6.2 LabSolutions Major Business
2.6.3 LabSolutions Hereditary Cancer Testing Product and Solutions
2.6.4 LabSolutions Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 LabSolutions Recent Developments and Future Plans
2.7 Progenity?Inc
2.7.1 Progenity?Inc Details
2.7.2 Progenity?Inc Major Business
2.7.3 Progenity?Inc Hereditary Cancer Testing Product and Solutions
2.7.4 Progenity?Inc Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Progenity?Inc Recent Developments and Future Plans
2.8 ARUP Laboratories
2.8.1 ARUP Laboratories Details
2.8.2 ARUP Laboratories Major Business
2.8.3 ARUP Laboratories Hereditary Cancer Testing Product and Solutions
2.8.4 ARUP Laboratories Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 ARUP Laboratories Recent Developments and Future Plans
2.9 Myriad
2.9.1 Myriad Details
2.9.2 Myriad Major Business
2.9.3 Myriad Hereditary Cancer Testing Product and Solutions
2.9.4 Myriad Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Myriad Recent Developments and Future Plans
2.10 NeoGenomics
2.10.1 NeoGenomics Details
2.10.2 NeoGenomics Major Business
2.10.3 NeoGenomics Hereditary Cancer Testing Product and Solutions
2.10.4 NeoGenomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 NeoGenomics Recent Developments and Future Plans
2.11 Blueprint Genetics
2.11.1 Blueprint Genetics Details
2.11.2 Blueprint Genetics Major Business
2.11.3 Blueprint Genetics Hereditary Cancer Testing Product and Solutions
2.11.4 Blueprint Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Blueprint Genetics Recent Developments and Future Plans
2.12 CellMax Life
2.12.1 CellMax Life Details
2.12.2 CellMax Life Major Business
2.12.3 CellMax Life Hereditary Cancer Testing Product and Solutions
2.12.4 CellMax Life Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 CellMax Life Recent Developments and Future Plans
2.13 Fulgent Genetics
2.13.1 Fulgent Genetics Details
2.13.2 Fulgent Genetics Major Business
2.13.3 Fulgent Genetics Hereditary Cancer Testing Product and Solutions
2.13.4 Fulgent Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Fulgent Genetics Recent Developments and Future Plans
2.14 Strand Life Sciences
2.14.1 Strand Life Sciences Details
2.14.2 Strand Life Sciences Major Business
2.14.3 Strand Life Sciences Hereditary Cancer Testing Product and Solutions
2.14.4 Strand Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Strand Life Sciences Recent Developments and Future Plans
2.15 Myogenes
2.15.1 Myogenes Details
2.15.2 Myogenes Major Business
2.15.3 Myogenes Hereditary Cancer Testing Product and Solutions
2.15.4 Myogenes Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Myogenes Recent Developments and Future Plans
2.16 LabCorp
2.16.1 LabCorp Details
2.16.2 LabCorp Major Business
2.16.3 LabCorp Hereditary Cancer Testing Product and Solutions
2.16.4 LabCorp Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 LabCorp Recent Developments and Future Plans
2.17 Quest Diagnostics
2.17.1 Quest Diagnostics Details
2.17.2 Quest Diagnostics Major Business
2.17.3 Quest Diagnostics Hereditary Cancer Testing Product and Solutions
2.17.4 Quest Diagnostics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Quest Diagnostics Recent Developments and Future Plans
2.18 Pathway Genomics
2.18.1 Pathway Genomics Details
2.18.2 Pathway Genomics Major Business
2.18.3 Pathway Genomics Hereditary Cancer Testing Product and Solutions
2.18.4 Pathway Genomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Pathway Genomics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Cancer Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Hereditary Cancer Testing Players Market Share in 2021
3.2.2 Top 10 Hereditary Cancer Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Hereditary Cancer Testing Players Head Office, Products and Services Provided
3.4 Hereditary Cancer Testing Mergers & Acquisitions
3.5 Hereditary Cancer Testing New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Cancer Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Hereditary Cancer Testing Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Cancer Testing Revenue Market Share by Application (2017-2022)
5.2 Global Hereditary Cancer Testing Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Hereditary Cancer Testing Revenue by Type (2017-2028)
6.2 North America Hereditary Cancer Testing Revenue by Application (2017-2028)
6.3 North America Hereditary Cancer Testing Market Size by Country
6.3.1 North America Hereditary Cancer Testing Revenue by Country (2017-2028)
6.3.2 United States Hereditary Cancer Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Hereditary Cancer Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Hereditary Cancer Testing Revenue by Type (2017-2028)
7.2 Europe Hereditary Cancer Testing Revenue by Application (2017-2028)
7.3 Europe Hereditary Cancer Testing Market Size by Country
7.3.1 Europe Hereditary Cancer Testing Revenue by Country (2017-2028)
7.3.2 Germany Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.3 France Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Hereditary Cancer Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Hereditary Cancer Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Region
8.3.1 Asia-Pacific Hereditary Cancer Testing Revenue by Region (2017-2028)
8.3.2 China Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.5 India Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Hereditary Cancer Testing Revenue by Type (2017-2028)
9.2 South America Hereditary Cancer Testing Revenue by Application (2017-2028)
9.3 South America Hereditary Cancer Testing Market Size by Country
9.3.1 South America Hereditary Cancer Testing Revenue by Country (2017-2028)
9.3.2 Brazil Hereditary Cancer Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Hereditary Cancer Testing Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Hereditary Cancer Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Hereditary Cancer Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country
10.3.1 Middle East & Africa Hereditary Cancer Testing Revenue by Country (2017-2028)
10.3.2 Turkey Hereditary Cancer Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Hereditary Cancer Testing Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Hereditary Cancer Testing
1.2 Classification of Hereditary Cancer Testing by Type
1.2.1 Overview: Global Hereditary Cancer Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Hereditary Cancer Testing Revenue Market Share by Type in 2021
1.2.3 RNA Testing
1.2.4 DNA Testing
1.3 Global Hereditary Cancer Testing Market by Application
1.3.1 Overview: Global Hereditary Cancer Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Global Hereditary Cancer Testing Market Size & Forecast
1.5 Global Hereditary Cancer Testing Market Size and Forecast by Region
1.5.1 Global Hereditary Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Hereditary Cancer Testing Market Size by Region, (2017-2022)
1.5.3 North America Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.6 South America Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Hereditary Cancer Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hereditary Cancer Testing Market Drivers
1.6.2 Hereditary Cancer Testing Market Restraints
1.6.3 Hereditary Cancer Testing Trends Analysis
2 COMPANY PROFILES
2.1 Ambry Genetics (Konica Minota)
2.1.1 Ambry Genetics (Konica Minota) Details
2.1.2 Ambry Genetics (Konica Minota) Major Business
2.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product and Solutions
2.1.4 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Ambry Genetics (Konica Minota) Recent Developments and Future Plans
2.2 Asper Biogene
2.2.1 Asper Biogene Details
2.2.2 Asper Biogene Major Business
2.2.3 Asper Biogene Hereditary Cancer Testing Product and Solutions
2.2.4 Asper Biogene Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Asper Biogene Recent Developments and Future Plans
2.3 Natera
2.3.1 Natera Details
2.3.2 Natera Major Business
2.3.3 Natera Hereditary Cancer Testing Product and Solutions
2.3.4 Natera Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Natera Recent Developments and Future Plans
2.4 Caris Life Sciences
2.4.1 Caris Life Sciences Details
2.4.2 Caris Life Sciences Major Business
2.4.3 Caris Life Sciences Hereditary Cancer Testing Product and Solutions
2.4.4 Caris Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Caris Life Sciences Recent Developments and Future Plans
2.5 BioReference Laboratories (GeneDx)
2.5.1 BioReference Laboratories (GeneDx) Details
2.5.2 BioReference Laboratories (GeneDx) Major Business
2.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product and Solutions
2.5.4 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BioReference Laboratories (GeneDx) Recent Developments and Future Plans
2.6 LabSolutions
2.6.1 LabSolutions Details
2.6.2 LabSolutions Major Business
2.6.3 LabSolutions Hereditary Cancer Testing Product and Solutions
2.6.4 LabSolutions Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 LabSolutions Recent Developments and Future Plans
2.7 Progenity?Inc
2.7.1 Progenity?Inc Details
2.7.2 Progenity?Inc Major Business
2.7.3 Progenity?Inc Hereditary Cancer Testing Product and Solutions
2.7.4 Progenity?Inc Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Progenity?Inc Recent Developments and Future Plans
2.8 ARUP Laboratories
2.8.1 ARUP Laboratories Details
2.8.2 ARUP Laboratories Major Business
2.8.3 ARUP Laboratories Hereditary Cancer Testing Product and Solutions
2.8.4 ARUP Laboratories Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 ARUP Laboratories Recent Developments and Future Plans
2.9 Myriad
2.9.1 Myriad Details
2.9.2 Myriad Major Business
2.9.3 Myriad Hereditary Cancer Testing Product and Solutions
2.9.4 Myriad Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Myriad Recent Developments and Future Plans
2.10 NeoGenomics
2.10.1 NeoGenomics Details
2.10.2 NeoGenomics Major Business
2.10.3 NeoGenomics Hereditary Cancer Testing Product and Solutions
2.10.4 NeoGenomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 NeoGenomics Recent Developments and Future Plans
2.11 Blueprint Genetics
2.11.1 Blueprint Genetics Details
2.11.2 Blueprint Genetics Major Business
2.11.3 Blueprint Genetics Hereditary Cancer Testing Product and Solutions
2.11.4 Blueprint Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Blueprint Genetics Recent Developments and Future Plans
2.12 CellMax Life
2.12.1 CellMax Life Details
2.12.2 CellMax Life Major Business
2.12.3 CellMax Life Hereditary Cancer Testing Product and Solutions
2.12.4 CellMax Life Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 CellMax Life Recent Developments and Future Plans
2.13 Fulgent Genetics
2.13.1 Fulgent Genetics Details
2.13.2 Fulgent Genetics Major Business
2.13.3 Fulgent Genetics Hereditary Cancer Testing Product and Solutions
2.13.4 Fulgent Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Fulgent Genetics Recent Developments and Future Plans
2.14 Strand Life Sciences
2.14.1 Strand Life Sciences Details
2.14.2 Strand Life Sciences Major Business
2.14.3 Strand Life Sciences Hereditary Cancer Testing Product and Solutions
2.14.4 Strand Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Strand Life Sciences Recent Developments and Future Plans
2.15 Myogenes
2.15.1 Myogenes Details
2.15.2 Myogenes Major Business
2.15.3 Myogenes Hereditary Cancer Testing Product and Solutions
2.15.4 Myogenes Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Myogenes Recent Developments and Future Plans
2.16 LabCorp
2.16.1 LabCorp Details
2.16.2 LabCorp Major Business
2.16.3 LabCorp Hereditary Cancer Testing Product and Solutions
2.16.4 LabCorp Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 LabCorp Recent Developments and Future Plans
2.17 Quest Diagnostics
2.17.1 Quest Diagnostics Details
2.17.2 Quest Diagnostics Major Business
2.17.3 Quest Diagnostics Hereditary Cancer Testing Product and Solutions
2.17.4 Quest Diagnostics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Quest Diagnostics Recent Developments and Future Plans
2.18 Pathway Genomics
2.18.1 Pathway Genomics Details
2.18.2 Pathway Genomics Major Business
2.18.3 Pathway Genomics Hereditary Cancer Testing Product and Solutions
2.18.4 Pathway Genomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Pathway Genomics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Cancer Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Hereditary Cancer Testing Players Market Share in 2021
3.2.2 Top 10 Hereditary Cancer Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Hereditary Cancer Testing Players Head Office, Products and Services Provided
3.4 Hereditary Cancer Testing Mergers & Acquisitions
3.5 Hereditary Cancer Testing New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Cancer Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Hereditary Cancer Testing Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Cancer Testing Revenue Market Share by Application (2017-2022)
5.2 Global Hereditary Cancer Testing Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Hereditary Cancer Testing Revenue by Type (2017-2028)
6.2 North America Hereditary Cancer Testing Revenue by Application (2017-2028)
6.3 North America Hereditary Cancer Testing Market Size by Country
6.3.1 North America Hereditary Cancer Testing Revenue by Country (2017-2028)
6.3.2 United States Hereditary Cancer Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Hereditary Cancer Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Hereditary Cancer Testing Revenue by Type (2017-2028)
7.2 Europe Hereditary Cancer Testing Revenue by Application (2017-2028)
7.3 Europe Hereditary Cancer Testing Market Size by Country
7.3.1 Europe Hereditary Cancer Testing Revenue by Country (2017-2028)
7.3.2 Germany Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.3 France Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Hereditary Cancer Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Hereditary Cancer Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Region
8.3.1 Asia-Pacific Hereditary Cancer Testing Revenue by Region (2017-2028)
8.3.2 China Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.5 India Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Hereditary Cancer Testing Revenue by Type (2017-2028)
9.2 South America Hereditary Cancer Testing Revenue by Application (2017-2028)
9.3 South America Hereditary Cancer Testing Market Size by Country
9.3.1 South America Hereditary Cancer Testing Revenue by Country (2017-2028)
9.3.2 Brazil Hereditary Cancer Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Hereditary Cancer Testing Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Hereditary Cancer Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Hereditary Cancer Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Country
10.3.1 Middle East & Africa Hereditary Cancer Testing Revenue by Country (2017-2028)
10.3.2 Turkey Hereditary Cancer Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Hereditary Cancer Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Hereditary Cancer Testing Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Hereditary Cancer Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Hereditary Cancer Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Hereditary Cancer Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Hereditary Cancer Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Hereditary Cancer Testing Revenue Market Share by Region (2023-2028)
Table 6. Ambry Genetics (Konica Minota) Corporate Information, Head Office, and Major Competitors
Table 7. Ambry Genetics (Konica Minota) Major Business
Table 8. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product and Solutions
Table 9. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Asper Biogene Corporate Information, Head Office, and Major Competitors
Table 11. Asper Biogene Major Business
Table 12. Asper Biogene Hereditary Cancer Testing Product and Solutions
Table 13. Asper Biogene Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Natera Corporate Information, Head Office, and Major Competitors
Table 15. Natera Major Business
Table 16. Natera Hereditary Cancer Testing Product and Solutions
Table 17. Natera Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Caris Life Sciences Corporate Information, Head Office, and Major Competitors
Table 19. Caris Life Sciences Major Business
Table 20. Caris Life Sciences Hereditary Cancer Testing Product and Solutions
Table 21. Caris Life Sciences Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BioReference Laboratories (GeneDx) Corporate Information, Head Office, and Major Competitors
Table 23. BioReference Laboratories (GeneDx) Major Business
Table 24. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product and Solutions
Table 25. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. LabSolutions Corporate Information, Head Office, and Major Competitors
Table 27. LabSolutions Major Business
Table 28. LabSolutions Hereditary Cancer Testing Product and Solutions
Table 29. LabSolutions Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Progenity?Inc Corporate Information, Head Office, and Major Competitors
Table 31. Progenity?Inc Major Business
Table 32. Progenity?Inc Hereditary Cancer Testing Product and Solutions
Table 33. Progenity?Inc Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. ARUP Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. ARUP Laboratories Major Business
Table 36. ARUP Laboratories Hereditary Cancer Testing Product and Solutions
Table 37. ARUP Laboratories Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Myriad Corporate Information, Head Office, and Major Competitors
Table 39. Myriad Major Business
Table 40. Myriad Hereditary Cancer Testing Product and Solutions
Table 41. Myriad Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. NeoGenomics Corporate Information, Head Office, and Major Competitors
Table 43. NeoGenomics Major Business
Table 44. NeoGenomics Hereditary Cancer Testing Product and Solutions
Table 45. NeoGenomics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Blueprint Genetics Corporate Information, Head Office, and Major Competitors
Table 47. Blueprint Genetics Major Business
Table 48. Blueprint Genetics Hereditary Cancer Testing Product and Solutions
Table 49. Blueprint Genetics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. CellMax Life Corporate Information, Head Office, and Major Competitors
Table 51. CellMax Life Major Business
Table 52. CellMax Life Hereditary Cancer Testing Product and Solutions
Table 53. CellMax Life Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Fulgent Genetics Corporate Information, Head Office, and Major Competitors
Table 55. Fulgent Genetics Major Business
Table 56. Fulgent Genetics Hereditary Cancer Testing Product and Solutions
Table 57. Fulgent Genetics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Strand Life Sciences Corporate Information, Head Office, and Major Competitors
Table 59. Strand Life Sciences Major Business
Table 60. Strand Life Sciences Hereditary Cancer Testing Product and Solutions
Table 61. Strand Life Sciences Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Myogenes Corporate Information, Head Office, and Major Competitors
Table 63. Myogenes Major Business
Table 64. Myogenes Hereditary Cancer Testing Product and Solutions
Table 65. Myogenes Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. LabCorp Corporate Information, Head Office, and Major Competitors
Table 67. LabCorp Major Business
Table 68. LabCorp Hereditary Cancer Testing Product and Solutions
Table 69. LabCorp Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 71. Quest Diagnostics Major Business
Table 72. Quest Diagnostics Hereditary Cancer Testing Product and Solutions
Table 73. Quest Diagnostics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Pathway Genomics Corporate Information, Head Office, and Major Competitors
Table 75. Pathway Genomics Major Business
Table 76. Pathway Genomics Hereditary Cancer Testing Product and Solutions
Table 77. Pathway Genomics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global Hereditary Cancer Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global Hereditary Cancer Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of Hereditary Cancer Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Hereditary Cancer Testing Players Head Office, Products and Services Provided
Table 82. Hereditary Cancer Testing Mergers & Acquisitions in the Past Five Years
Table 83. Hereditary Cancer Testing New Entrants and Expansion Plans
Table 84. Global Hereditary Cancer Testing Revenue (USD Million) by Type (2017-2022)
Table 85. Global Hereditary Cancer Testing Revenue Share by Type (2017-2022)
Table 86. Global Hereditary Cancer Testing Revenue Forecast by Type (2023-2028)
Table 87. Global Hereditary Cancer Testing Revenue by Application (2017-2022)
Table 88. Global Hereditary Cancer Testing Revenue Forecast by Application (2023-2028)
Table 89. North America Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 90. North America Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 91. North America Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 92. North America Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 93. North America Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 94. North America Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific Hereditary Cancer Testing Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific Hereditary Cancer Testing Revenue by Region (2023-2028) & (USD Million)
Table 107. South America Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 108. South America Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 109. South America Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 110. South America Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 111. South America Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 112. South America Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Hereditary Cancer Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Hereditary Cancer Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Hereditary Cancer Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Hereditary Cancer Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Hereditary Cancer Testing Revenue Market Share by Region (2023-2028)
Table 6. Ambry Genetics (Konica Minota) Corporate Information, Head Office, and Major Competitors
Table 7. Ambry Genetics (Konica Minota) Major Business
Table 8. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product and Solutions
Table 9. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Asper Biogene Corporate Information, Head Office, and Major Competitors
Table 11. Asper Biogene Major Business
Table 12. Asper Biogene Hereditary Cancer Testing Product and Solutions
Table 13. Asper Biogene Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Natera Corporate Information, Head Office, and Major Competitors
Table 15. Natera Major Business
Table 16. Natera Hereditary Cancer Testing Product and Solutions
Table 17. Natera Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Caris Life Sciences Corporate Information, Head Office, and Major Competitors
Table 19. Caris Life Sciences Major Business
Table 20. Caris Life Sciences Hereditary Cancer Testing Product and Solutions
Table 21. Caris Life Sciences Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BioReference Laboratories (GeneDx) Corporate Information, Head Office, and Major Competitors
Table 23. BioReference Laboratories (GeneDx) Major Business
Table 24. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product and Solutions
Table 25. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. LabSolutions Corporate Information, Head Office, and Major Competitors
Table 27. LabSolutions Major Business
Table 28. LabSolutions Hereditary Cancer Testing Product and Solutions
Table 29. LabSolutions Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Progenity?Inc Corporate Information, Head Office, and Major Competitors
Table 31. Progenity?Inc Major Business
Table 32. Progenity?Inc Hereditary Cancer Testing Product and Solutions
Table 33. Progenity?Inc Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. ARUP Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. ARUP Laboratories Major Business
Table 36. ARUP Laboratories Hereditary Cancer Testing Product and Solutions
Table 37. ARUP Laboratories Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Myriad Corporate Information, Head Office, and Major Competitors
Table 39. Myriad Major Business
Table 40. Myriad Hereditary Cancer Testing Product and Solutions
Table 41. Myriad Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. NeoGenomics Corporate Information, Head Office, and Major Competitors
Table 43. NeoGenomics Major Business
Table 44. NeoGenomics Hereditary Cancer Testing Product and Solutions
Table 45. NeoGenomics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Blueprint Genetics Corporate Information, Head Office, and Major Competitors
Table 47. Blueprint Genetics Major Business
Table 48. Blueprint Genetics Hereditary Cancer Testing Product and Solutions
Table 49. Blueprint Genetics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. CellMax Life Corporate Information, Head Office, and Major Competitors
Table 51. CellMax Life Major Business
Table 52. CellMax Life Hereditary Cancer Testing Product and Solutions
Table 53. CellMax Life Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Fulgent Genetics Corporate Information, Head Office, and Major Competitors
Table 55. Fulgent Genetics Major Business
Table 56. Fulgent Genetics Hereditary Cancer Testing Product and Solutions
Table 57. Fulgent Genetics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Strand Life Sciences Corporate Information, Head Office, and Major Competitors
Table 59. Strand Life Sciences Major Business
Table 60. Strand Life Sciences Hereditary Cancer Testing Product and Solutions
Table 61. Strand Life Sciences Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Myogenes Corporate Information, Head Office, and Major Competitors
Table 63. Myogenes Major Business
Table 64. Myogenes Hereditary Cancer Testing Product and Solutions
Table 65. Myogenes Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. LabCorp Corporate Information, Head Office, and Major Competitors
Table 67. LabCorp Major Business
Table 68. LabCorp Hereditary Cancer Testing Product and Solutions
Table 69. LabCorp Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 71. Quest Diagnostics Major Business
Table 72. Quest Diagnostics Hereditary Cancer Testing Product and Solutions
Table 73. Quest Diagnostics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Pathway Genomics Corporate Information, Head Office, and Major Competitors
Table 75. Pathway Genomics Major Business
Table 76. Pathway Genomics Hereditary Cancer Testing Product and Solutions
Table 77. Pathway Genomics Hereditary Cancer Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global Hereditary Cancer Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global Hereditary Cancer Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of Hereditary Cancer Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Hereditary Cancer Testing Players Head Office, Products and Services Provided
Table 82. Hereditary Cancer Testing Mergers & Acquisitions in the Past Five Years
Table 83. Hereditary Cancer Testing New Entrants and Expansion Plans
Table 84. Global Hereditary Cancer Testing Revenue (USD Million) by Type (2017-2022)
Table 85. Global Hereditary Cancer Testing Revenue Share by Type (2017-2022)
Table 86. Global Hereditary Cancer Testing Revenue Forecast by Type (2023-2028)
Table 87. Global Hereditary Cancer Testing Revenue by Application (2017-2022)
Table 88. Global Hereditary Cancer Testing Revenue Forecast by Application (2023-2028)
Table 89. North America Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 90. North America Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 91. North America Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 92. North America Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 93. North America Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 94. North America Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific Hereditary Cancer Testing Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific Hereditary Cancer Testing Revenue by Region (2023-2028) & (USD Million)
Table 107. South America Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 108. South America Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 109. South America Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 110. South America Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 111. South America Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 112. South America Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa Hereditary Cancer Testing Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa Hereditary Cancer Testing Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa Hereditary Cancer Testing Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa Hereditary Cancer Testing Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa Hereditary Cancer Testing Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa Hereditary Cancer Testing Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Hereditary Cancer Testing Picture
Figure 2. Global Hereditary Cancer Testing Revenue Market Share by Type in 2021
Figure 3. RNA Testing
Figure 4. DNA Testing
Figure 5. Hereditary Cancer Testing Revenue Market Share by Application in 2021
Figure 6. Breast Cancer Picture
Figure 7. Gastrointestinal Cancer Picture
Figure 8. Prostate Cancer Picture
Figure 9. Respiratory/Lung Cancer Picture
Figure 10. Other Cancers Picture
Figure 11. Global Hereditary Cancer Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Hereditary Cancer Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Hereditary Cancer Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Hereditary Cancer Testing Revenue Market Share by Region in 2021
Figure 15. North America Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Hereditary Cancer Testing Market Drivers
Figure 21. Hereditary Cancer Testing Market Restraints
Figure 22. Hereditary Cancer Testing Market Trends
Figure 23. Ambry Genetics (Konica Minota) Recent Developments and Future Plans
Figure 24. Asper Biogene Recent Developments and Future Plans
Figure 25. Natera Recent Developments and Future Plans
Figure 26. Caris Life Sciences Recent Developments and Future Plans
Figure 27. BioReference Laboratories (GeneDx) Recent Developments and Future Plans
Figure 28. LabSolutions Recent Developments and Future Plans
Figure 29. Progenity?Inc Recent Developments and Future Plans
Figure 30. ARUP Laboratories Recent Developments and Future Plans
Figure 31. Myriad Recent Developments and Future Plans
Figure 32. NeoGenomics Recent Developments and Future Plans
Figure 33. Blueprint Genetics Recent Developments and Future Plans
Figure 34. CellMax Life Recent Developments and Future Plans
Figure 35. Fulgent Genetics Recent Developments and Future Plans
Figure 36. Strand Life Sciences Recent Developments and Future Plans
Figure 37. Myogenes Recent Developments and Future Plans
Figure 38. LabCorp Recent Developments and Future Plans
Figure 39. Quest Diagnostics Recent Developments and Future Plans
Figure 40. Pathway Genomics Recent Developments and Future Plans
Figure 41. Global Hereditary Cancer Testing Revenue Share by Players in 2021
Figure 42. Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Hereditary Cancer Testing Revenue Market Share in 2021
Figure 44. Global Top 10 Players Hereditary Cancer Testing Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Hereditary Cancer Testing Revenue Share by Type in 2021
Figure 47. Global Hereditary Cancer Testing Market Share Forecast by Type (2023-2028)
Figure 48. Global Hereditary Cancer Testing Revenue Share by Application in 2021
Figure 49. Global Hereditary Cancer Testing Market Share Forecast by Application (2023-2028)
Figure 50. North America Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 51. North America Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 52. North America Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 53. United States Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 57. Europe Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 58. Europe Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 59. Germany Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Hereditary Cancer Testing Revenue Market Share by Region (2017-2028)
Figure 67. China Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 74. South America Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 75. South America Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Hereditary Cancer Testing Picture
Figure 2. Global Hereditary Cancer Testing Revenue Market Share by Type in 2021
Figure 3. RNA Testing
Figure 4. DNA Testing
Figure 5. Hereditary Cancer Testing Revenue Market Share by Application in 2021
Figure 6. Breast Cancer Picture
Figure 7. Gastrointestinal Cancer Picture
Figure 8. Prostate Cancer Picture
Figure 9. Respiratory/Lung Cancer Picture
Figure 10. Other Cancers Picture
Figure 11. Global Hereditary Cancer Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Hereditary Cancer Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Hereditary Cancer Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Hereditary Cancer Testing Revenue Market Share by Region in 2021
Figure 15. North America Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Hereditary Cancer Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Hereditary Cancer Testing Market Drivers
Figure 21. Hereditary Cancer Testing Market Restraints
Figure 22. Hereditary Cancer Testing Market Trends
Figure 23. Ambry Genetics (Konica Minota) Recent Developments and Future Plans
Figure 24. Asper Biogene Recent Developments and Future Plans
Figure 25. Natera Recent Developments and Future Plans
Figure 26. Caris Life Sciences Recent Developments and Future Plans
Figure 27. BioReference Laboratories (GeneDx) Recent Developments and Future Plans
Figure 28. LabSolutions Recent Developments and Future Plans
Figure 29. Progenity?Inc Recent Developments and Future Plans
Figure 30. ARUP Laboratories Recent Developments and Future Plans
Figure 31. Myriad Recent Developments and Future Plans
Figure 32. NeoGenomics Recent Developments and Future Plans
Figure 33. Blueprint Genetics Recent Developments and Future Plans
Figure 34. CellMax Life Recent Developments and Future Plans
Figure 35. Fulgent Genetics Recent Developments and Future Plans
Figure 36. Strand Life Sciences Recent Developments and Future Plans
Figure 37. Myogenes Recent Developments and Future Plans
Figure 38. LabCorp Recent Developments and Future Plans
Figure 39. Quest Diagnostics Recent Developments and Future Plans
Figure 40. Pathway Genomics Recent Developments and Future Plans
Figure 41. Global Hereditary Cancer Testing Revenue Share by Players in 2021
Figure 42. Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Hereditary Cancer Testing Revenue Market Share in 2021
Figure 44. Global Top 10 Players Hereditary Cancer Testing Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Hereditary Cancer Testing Revenue Share by Type in 2021
Figure 47. Global Hereditary Cancer Testing Market Share Forecast by Type (2023-2028)
Figure 48. Global Hereditary Cancer Testing Revenue Share by Application in 2021
Figure 49. Global Hereditary Cancer Testing Market Share Forecast by Application (2023-2028)
Figure 50. North America Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 51. North America Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 52. North America Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 53. United States Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 57. Europe Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 58. Europe Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 59. Germany Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Hereditary Cancer Testing Revenue Market Share by Region (2017-2028)
Figure 67. China Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 74. South America Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 75. South America Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Hereditary Cancer Testing Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Hereditary Cancer Testing Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Hereditary Cancer Testing Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Hereditary Cancer Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
